BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 23300448)

  • 1. Statins decrease neuroinflammation and prevent cognitive impairment after cerebral malaria.
    Reis PA; Estato V; da Silva TI; d'Avila JC; Siqueira LD; Assis EF; Bozza PT; Bozza FA; Tibiriça EV; Zimmerman GA; Castro-Faria-Neto HC
    PLoS Pathog; 2012 Dec; 8(12):e1003099. PubMed ID: 23300448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy.
    Reis PA; Comim CM; Hermani F; Silva B; Barichello T; Portella AC; Gomes FC; Sab IM; Frutuoso VS; Oliveira MF; Bozza PT; Bozza FA; Dal-Pizzol F; Zimmerman GA; Quevedo J; Castro-Faria-Neto HC
    PLoS Pathog; 2010 Jun; 6(6):e1000963. PubMed ID: 20585569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor (VEGF) and lovastatin suppress the inflammatory response to Plasmodium berghei infection and protect against experimental cerebral malaria.
    Canavese M; Crisanti A
    Pathog Glob Health; 2015 Sep; 109(6):266-74. PubMed ID: 26392164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous nitric oxide decreases brain vascular inflammation, leakage and venular resistance during Plasmodium berghei ANKA infection in mice.
    Zanini GM; Cabrales P; Barkho W; Frangos JA; Carvalho LJ
    J Neuroinflammation; 2011 Jun; 8():66. PubMed ID: 21649904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Neuroprotective Effect of the Glutamate Receptor Antagonist MK801 on Long-Term Cognitive and Behavioral Outcomes Secondary to Experimental Cerebral Malaria.
    de Miranda AS; Brant F; Vieira LB; Rocha NP; Vieira ÉLM; Rezende GHS; de Oliveira Pimentel PM; Moraes MFD; Ribeiro FM; Ransohoff RM; Teixeira MM; Machado FS; Rachid MA; Teixeira AL
    Mol Neurobiol; 2017 Nov; 54(9):7063-7082. PubMed ID: 27796746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins prevent cognitive impairment after sepsis by reverting neuroinflammation, and microcirculatory/endothelial dysfunction.
    Reis PA; Alexandre PCB; D'Avila JC; Siqueira LD; Antunes B; Estato V; Tibiriça EV; Verdonk F; Sharshar T; Chrétien F; Castro-Faria-Neto HC; Bozza FA
    Brain Behav Immun; 2017 Feb; 60():293-303. PubMed ID: 27833044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered regulation of Akt signaling with murine cerebral malaria, effects on long-term neuro-cognitive function, restoration with lithium treatment.
    Dai M; Freeman B; Shikani HJ; Bruno FP; Collado JE; Macias R; Reznik SE; Davies P; Spray DC; Tanowitz HB; Weiss LM; Desruisseaux MS
    PLoS One; 2012; 7(10):e44117. PubMed ID: 23082110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuregulin-1 attenuates mortality associated with experimental cerebral malaria.
    Solomon W; Wilson NO; Anderson L; Pitts S; Patrickson J; Liu M; Ford BD; Stiles JK
    J Neuroinflammation; 2014 Jan; 11():9. PubMed ID: 24433482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrin αDβ2 influences cerebral edema, leukocyte accumulation and neurologic outcomes in experimental severe malaria.
    Azevedo-Quintanilha IG; Vieira-de-Abreu A; Ferreira AC; Reis PA; Silva TI; Nascimento DO; Campbell RA; Estato V; Weyrich AS; Bozza PT; Zimmerman GA; Castro-Faria-Neto HC
    PLoS One; 2019; 14(12):e0224610. PubMed ID: 31869339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further evidence for an anti-inflammatory role of artesunate in experimental cerebral malaria.
    Miranda AS; Brant F; Rocha NP; Cisalpino D; Rodrigues DH; Souza DG; Machado FS; Rachid MA; Teixeira AL; Campos AC
    Malar J; 2013 Nov; 12():388. PubMed ID: 24180288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrier.
    Nacer A; Movila A; Sohet F; Girgis NM; Gundra UM; Loke P; Daneman R; Frevert U
    PLoS Pathog; 2014 Dec; 10(12):e1004528. PubMed ID: 25474413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia.
    Weber C; Erl W; Weber KS; Weber PC
    J Am Coll Cardiol; 1997 Nov; 30(5):1212-7. PubMed ID: 9350917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressor of cytokine signaling 2 modulates the immune response profile and development of experimental cerebral malaria.
    Brant F; Miranda AS; Esper L; Gualdrón-López M; Cisalpino D; de Souza DDG; Rachid MA; Tanowitz HB; Teixeira MM; Teixeira AL; Machado FS
    Brain Behav Immun; 2016 May; 54():73-85. PubMed ID: 26765997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minocycline prevents cerebral malaria, confers neuroprotection and increases survivability of mice during Plasmodium berghei ANKA infection.
    Apoorv TS; Babu PP
    Cytokine; 2017 Feb; 90():113-123. PubMed ID: 27865203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic administration of HMG-CoA reductase inhibitor protects the blood-retinal barrier and ameliorates retinal inflammation in type 2 diabetes.
    Li J; Wang JJ; Chen D; Mott R; Yu Q; Ma JX; Zhang SX
    Exp Eye Res; 2009 Jun; 89(1):71-8. PubMed ID: 19254713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effect of uncomplicated Plasmodium berghei ANKA malaria on memory and anxiety-like behaviour in C57BL/6 mice.
    de Sousa LP; de Almeida RF; Ribeiro-Gomes FL; de Moura Carvalho LJ; E Souza TM; de Souza DOG; Daniel-Ribeiro CT
    Parasit Vectors; 2018 Mar; 11(1):191. PubMed ID: 29554958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte Locomotion Inhibitory Factor confers neuroprotection and prevents the development of murine cerebral malaria.
    Galán-Salinas A; Corral-Ruíz G; Pérez-Vega MJ; Fabila-Castillo L; Silva-García R; Marquina-Castillo B; León-Contreras JC; Barrios-Payán J; Francisco-Cruz A; Montecillo-Aguado M; Huerta-Yepez S; Calderón-Amador J; Flores-Romo L; Hernández-Pando R; Sánchez-Torres LE
    Int Immunopharmacol; 2021 Aug; 97():107674. PubMed ID: 34044183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stromal cells protect against vascular damage and depression-like behavior in mice surviving cerebral malaria.
    Lima MN; Oliveira HA; Fagundes PM; Estato V; Silva AYO; Freitas RJRX; Passos BABR; Oliveira KS; Batista CN; Vallochi AL; Rocco PRM; Castro-Faria-Neto HC; Maron-Gutierrez T
    Stem Cell Res Ther; 2020 Aug; 11(1):367. PubMed ID: 32843073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain endothelial STING1 activation by
    Pais TF; Ali H; Moreira da Silva J; Duarte N; Neres R; Chhatbar C; Acúrcio RC; Guedes RC; Strano Moraes MC; Costa-Silva B; Kalinke U; Penha-Gonçalves C
    Proc Natl Acad Sci U S A; 2022 Sep; 119(36):e2206327119. PubMed ID: 36037380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive dysfunction in mice infected with Plasmodium berghei strain ANKA.
    Desruisseaux MS; Gulinello M; Smith DN; Lee SC; Tsuji M; Weiss LM; Spray DC; Tanowitz HB
    J Infect Dis; 2008 Jun; 197(11):1621-7. PubMed ID: 18419550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.